Compare HCA Health Inc (HCA) vs Lumen Technologies Inc (LUMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Lumen Technologies Inc — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while Lumen Technologies Inc trades at $6.76 (market cap $6.47B). The key difference: HCA Health Inc is far larger — about 12.7× Lumen Technologies Inc's market cap, and HCA Health Inc pays a 0.84% dividend while Lumen Technologies Inc pays none. Which is the better fit depends on your goals.
| HCA | LUMN | |
|---|---|---|
Market Cap | $82.17B | $6.47B |
Sector | Health | Media |
52-Week High | $545.13 | $11.83 |
52-Week Low | $334.32 | $3.70 |
Enterprise Value | $131.08B | $18.10B |
Dividend Yield | 0.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $373.09, up 0.51% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 preliminary revenue above expectations but cut full-year profit guidance, causing recent stock pressure. Analyst consensus remains bullish with a $469.40 price target, though multiple law firms are investigating potential securities law violations following the guidance revision.
Investment outlook balances strong operational performance against near-term headwinds. The stock offers value with a 12.76 P/E ratio and consistent earnings beats, but faces risks from rising expenses, payer mix challenges, and ongoing legal investigations. Institutional sentiment remains positive despite technical weakness and recent guidance concerns.
LUMN trades at $6.76, up 7.64% today, but remains in a bearish technical trend with resistance at $7. The company reported a net loss of $1.74B in 2025 despite beating EPS estimates in two of the last three quarters. Recent news highlights AI-focused initiatives, including the acquisition of Alkira and recognition in Gartner's AI vendor report, signaling strategic repositioning amid declining revenue.
The outlook is cautious with high debt ($17.49B long-term) and negative profitability metrics posing significant risks. Analyst consensus is mixed (14% Buy, 61% Hold) with a $8.25 price target, suggesting limited upside. Investors should weigh cost-cutting progress and AI contract growth against persistent cash flow challenges and competitive pressures in telecom services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →
